Friday, November 22, 2013

Diabetic Macular Edema Vision Loss & Lucentis® Injections

For Birmingham patients with diabetes who are at risk for diabetic macular edema, a significant cause of vision loss and an associated complication of diabetic retinopathy, Lucentis® eye injections work to treat diabetic macular edema, or swelling of the macula. Diabetic macular edema is a leading cause of vision loss associated with diabetes. Lucentis® has been used for some time to treat “wet” age-related macular degeneration (AMD). Lucentis® is the first drug FDA approved to treat diabetic macular edema. More than 500,000 people in the U.S. have diabetic eye disease and before Lucentis® had to have laser treatment to address this complication of diabetic retinopathy. “The use of Lucentis® to treat diabetic macular edema gives ophthalmologists a great tool and a significant advantage in managing vision loss from diabetes,” commented Tyler Hall, M.D of Alabama Eye & Cataract Center in Birmingham, AL.

If you or someone you know has questions or needs an eye exam to learn about diabetic eye disease or the problems from diabetic retinopathy such as diabetic macular edema please feel free to call Alabama Eye & Cataract Center in Birmingham at 205-930-0930, visit Alabama Eye & Cataract Center or

Michelson Laser Vision, 327 Summit Boulevard, Birmingham, Alabama 35243 and Alabama Eye & Cataract Center, 1201 11th Avenue S, Suite 501, Birmingham, Alabama 35205 are leading eye care centers in Birmingham.